• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

以及作为慢性鼻-鼻窦炎和头颈癌潜在生物标志物的表达水平。

and Expression Levels as a Potential Biomarker of Chronic Rhinosinusitis and Head and Neck Cancers.

作者信息

Malinowska Katarzyna, Kowalski Andrzej, Merecz-Sadowska Anna, Paprocka-Zjawiona Milena, Sitarek Przemysław, Kowalczyk Tomasz, Zielińska-Bliźniewska Hanna

机构信息

Department of Allergology and Respiratory Rehabilitation, Medical University of Lodz, 90-725 Lodz, Poland.

Department of Otolaryngology, Laryngological Oncology, Audiology and Phoniatrics, Medical University of Lodz, 90-549 Lodz, Poland.

出版信息

J Clin Med. 2023 Mar 3;12(5):2033. doi: 10.3390/jcm12052033.

DOI:10.3390/jcm12052033
PMID:36902820
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10004389/
Abstract

Inflammation is an etiological factor of various chronic diseases contributing to more than 50% of worldwide deaths. In this study, we focus on the immunosuppressive role of the programmed death-1 (PD-1) receptor and its ligand (PD-L1) in inflammatory-related diseases, including chronic rhinosinusitis and head and neck cancers. The study included 304 participants. Of this number, 162 patients had chronic rhinosinusitis with nasal polyps (CRSwNP), 40 patients had head and neck cancer (HNC) and there were 102 healthy subjects. The expression level of the and genes in the tissues of the study groups was measured by qPCR and Western blot methods. The associations between the age of the patients and the extent of disease and genes' expression were evaluated. The study showed a significantly higher mRNA expression of and in the tissues of both the CRSwNP and HNC patient groups compared to the healthy group. The severity of CRSwNP significantly correlated with the mRNA expression of and . Similarly, the age of the NHC patients influenced expression. In addition, a significantly higher level of PD-L1 protein was noticed also for both the CRSwNP and HNC patient groups. The increased expression of and may be a potential biomarker of inflammatory-related diseases, including chronic rhinosinusitis and head and neck cancers.

摘要

炎症是多种慢性疾病的病因,全球超过50%的死亡与之相关。在本研究中,我们聚焦于程序性死亡-1(PD-1)受体及其配体(PD-L1)在炎症相关疾病中的免疫抑制作用,这些疾病包括慢性鼻-鼻窦炎和头颈部癌症。该研究纳入了304名参与者。其中,162例患者患有伴鼻息肉的慢性鼻-鼻窦炎(CRSwNP),40例患者患有头颈部癌症(HNC),还有102名健康受试者。通过qPCR和蛋白质印迹法检测研究组组织中 和 基因的表达水平。评估患者年龄与疾病程度及基因表达之间的关联。研究表明,与健康组相比,CRSwNP和HNC患者组组织中 和 的mRNA表达均显著更高。CRSwNP的严重程度与 和 的mRNA表达显著相关。同样,NHC患者的年龄影响 表达。此外,CRSwNP和HNC患者组的PD-L1蛋白水平也均显著更高。 和 表达的增加可能是包括慢性鼻-鼻窦炎和头颈部癌症在内的炎症相关疾病的潜在生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/758d/10004389/d9085ea3226f/jcm-12-02033-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/758d/10004389/fda7ab8dd934/jcm-12-02033-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/758d/10004389/89795d664bd9/jcm-12-02033-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/758d/10004389/0a7a6e57312c/jcm-12-02033-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/758d/10004389/d9085ea3226f/jcm-12-02033-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/758d/10004389/fda7ab8dd934/jcm-12-02033-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/758d/10004389/89795d664bd9/jcm-12-02033-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/758d/10004389/0a7a6e57312c/jcm-12-02033-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/758d/10004389/d9085ea3226f/jcm-12-02033-g004.jpg

相似文献

1
and Expression Levels as a Potential Biomarker of Chronic Rhinosinusitis and Head and Neck Cancers.以及作为慢性鼻-鼻窦炎和头颈癌潜在生物标志物的表达水平。
J Clin Med. 2023 Mar 3;12(5):2033. doi: 10.3390/jcm12052033.
2
Programmed cell death-1 expression correlates with disease severity and IL-5 in chronic rhinosinusitis with nasal polyps.程序性细胞死亡受体-1 的表达与慢性鼻-鼻窦炎伴鼻息肉患者的疾病严重程度和白细胞介素-5 相关。
Allergy. 2017 Jun;72(6):985-993. doi: 10.1111/all.13136. Epub 2017 Mar 6.
3
Prognostic role of programmed cell death ligand-1 expression in head and neck cancer treated with programmed cell death protein-1/programmed cell death ligand-1 inhibitors: A meta-analysis based on clinical trials.程序性细胞死亡配体 1 表达在接受程序性细胞死亡蛋白 1/程序性细胞死亡配体 1 抑制剂治疗的头颈部癌症中的预后作用:基于临床试验的荟萃分析。
J Cancer Res Ther. 2021 Jul;17(3):676-687. doi: 10.4103/jcrt.JCRT_1606_20.
4
CDK5 Regulates PD-L1 Expression and Cell Maturation in Dendritic Cells of CRSwNP.CDK5 调节 CRSwNP 树突状细胞中 PD-L1 的表达和细胞成熟。
Inflammation. 2019 Feb;42(1):135-144. doi: 10.1007/s10753-018-0879-3.
5
PD-1 and PDL-1 gene expression in nasal polyp tissue from patients with asthma exacerbated by non-steroidal anti-inflammatory drugs correlates with the severity of the disease.PD-1 和 PDL-1 基因在非甾体类抗炎药诱发哮喘患者鼻息肉组织中的表达与疾病严重程度相关。
Otolaryngol Pol. 2023 Jan 22;77(2):1-5. doi: 10.5604/01.3001.0016.2204.
6
The antimicrobial protein short palate, lung, and nasal epithelium clone 1 (SPLUNC1) is differentially modulated in eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps.抗菌蛋白短 palate、肺和鼻上皮克隆 1(SPLUNC1)在伴有鼻息肉的嗜酸性粒细胞性和非嗜酸性粒细胞性慢性鼻-鼻窦炎中存在差异调节。
J Allergy Clin Immunol. 2014 Feb;133(2):420-8. doi: 10.1016/j.jaci.2013.09.052. Epub 2013 Dec 15.
7
Disease-specific T-helper cell polarizing function of lesional dendritic cells in different types of chronic rhinosinusitis with nasal polyps.不同类型鼻息肉慢性鼻窦炎皮损树突状细胞的疾病特异性 T 辅助细胞极化功能。
Am J Respir Crit Care Med. 2014 Sep 15;190(6):628-38. doi: 10.1164/rccm.201402-0234OC.
8
Predictive value of S100A4 in eosinophilic chronic rhinosinusitis with nasal polyps.S100A4在嗜酸性粒细胞性慢性鼻-鼻窦炎伴鼻息肉中的预测价值。
Front Surg. 2022 Nov 1;9:989489. doi: 10.3389/fsurg.2022.989489. eCollection 2022.
9
[The expression and significance of TRPM8 among chronic rhinosinusitis with nasal polyps].[瞬时受体电位阳离子通道亚家族M成员8在鼻息肉型慢性鼻-鼻窦炎中的表达及意义]
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2021 Oct 7;56(10):1059-1065. doi: 10.3760/cma.j.cn115330-20210430-00243.
10
Identification of the Cell-Intrinsic and -Extrinsic Pathways Downstream of EGFR and IFNγ That Induce PD-L1 Expression in Head and Neck Cancer.鉴定表皮生长因子受体(EGFR)和γ干扰素(IFNγ)下游在头颈部癌中诱导程序性死亡配体1(PD-L1)表达的细胞内源性和外源性途径。
Cancer Res. 2016 Mar 1;76(5):1031-43. doi: 10.1158/0008-5472.CAN-15-2001. Epub 2015 Dec 16.

引用本文的文献

1
A Raman topography imaging method toward assisting surgical tumor resection.一种辅助手术肿瘤切除的拉曼形貌成像方法。
Npj Imaging. 2024;2(1). doi: 10.1038/s44303-024-00006-6. Epub 2024 Feb 19.
2
Salivary biomarkers: a promising approach for predicting immunotherapy response in head and neck cancers.唾液生物标志物:预测头颈癌免疫治疗反应的一种有前景的方法。
Clin Transl Oncol. 2025 May;27(5):1887-1920. doi: 10.1007/s12094-024-03742-8. Epub 2024 Oct 8.
3
Epithelial‑derived head and neck squamous tumourigenesis (Review).上皮来源的头颈部鳞状肿瘤发生(综述)。

本文引用的文献

1
Programmed Cell Death-Ligand 1 in Head and Neck Squamous Cell Carcinoma: Molecular Insights, Preclinical and Clinical Data, and Therapies.程序性细胞死亡配体 1 在下咽鳞状细胞癌中的作用:分子见解、临床前和临床数据以及治疗方法。
Int J Mol Sci. 2022 Dec 6;23(23):15384. doi: 10.3390/ijms232315384.
2
The role of PD-1/PD-L1 and application of immune-checkpoint inhibitors in human cancers.PD-1/PD-L1 通路及其免疫检查点抑制剂在人类癌症中的应用。
Front Immunol. 2022 Sep 13;13:964442. doi: 10.3389/fimmu.2022.964442. eCollection 2022.
3
Relationship between Chronic Rhinosinusitis and the Incidence of Head and Neck Cancer: A National Population-Based Study.
Oncol Rep. 2024 Oct;52(4). doi: 10.3892/or.2024.8800. Epub 2024 Sep 2.
4
Tumor-Agnostic Therapy-The Final Step Forward in the Cure for Human Neoplasms?肿瘤不可知疗法——人类肿瘤治愈的最后一步?
Cells. 2024 Jun 20;13(12):1071. doi: 10.3390/cells13121071.
慢性鼻-鼻窦炎与头颈癌发病率之间的关系:一项基于全国人口的研究。
J Clin Med. 2022 Sep 9;11(18):5316. doi: 10.3390/jcm11185316.
4
PD-L1 regulates cell proliferation and apoptosis in acute myeloid leukemia by activating PI3K-AKT signaling pathway.PD-L1 通过激活 PI3K-AKT 信号通路调节急性髓系白血病细胞的增殖和凋亡。
Sci Rep. 2022 Jul 6;12(1):11444. doi: 10.1038/s41598-022-15020-0.
5
Very high PD-L1 expression as a prognostic indicator of overall survival among patients with advanced non-small cell lung cancer receiving anti-PD-(L)1 monotherapies in routine practice.在常规实践中,接受抗 PD-(L)1 单药治疗的晚期非小细胞肺癌患者中,非常高的 PD-L1 表达可作为总生存期的预后指标。
Pharmacoepidemiol Drug Saf. 2022 Oct;31(10):1121-1126. doi: 10.1002/pds.5487. Epub 2022 Jun 22.
6
Immunotherapy for head and neck cancer: Present and future.头颈部癌症的免疫治疗:现状与未来。
Crit Rev Oncol Hematol. 2022 Jun;174:103679. doi: 10.1016/j.critrevonc.2022.103679. Epub 2022 Apr 6.
7
PD-1/PD-L1 Inhibitors in Patients With Preexisting Autoimmune Diseases.预先存在自身免疫性疾病患者中的PD-1/PD-L1抑制剂
Front Pharmacol. 2022 Mar 18;13:854967. doi: 10.3389/fphar.2022.854967. eCollection 2022.
8
Tumor-Infiltrating Lymphocytes in Head and Neck Cancer: Ready for Prime Time?头颈癌中的肿瘤浸润淋巴细胞:准备好进入黄金时代了吗?
Cancers (Basel). 2022 Mar 18;14(6):1558. doi: 10.3390/cancers14061558.
9
Mechanisms and pathogenesis of chronic rhinosinusitis.慢性鼻-鼻窦炎的发病机制和病理生理学。
J Allergy Clin Immunol. 2022 May;149(5):1491-1503. doi: 10.1016/j.jaci.2022.02.016. Epub 2022 Mar 1.
10
PD-L1 upregulation is associated with activation of the DNA double-strand break repair pathway in patients with colitic cancer.PD-L1 的上调与结肠炎相关癌症患者的 DNA 双链断裂修复途径的激活有关。
Sci Rep. 2021 Jun 22;11(1):13077. doi: 10.1038/s41598-021-92530-3.